Kinnari Patel - President, Head of R&D and Chief Operating Officer at Rocket Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, Head of R&D and Chief Operating Officer
Stock Symbol
RCKT, RCKTW on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Kinnari Patel - trading volume in the past year for Rocket Pharmaceuticals, Inc.

Holdings reported by Kinnari Patel for Rocket Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 397K $7.35M $18.50 Aug 16, 2024 Direct
Common Stock 105K $1.94M $18.50 Aug 16, 2024 By Adaptive Technology LLC
Stock Option (Right to Buy) 98.2K $1.23M $12.55 Feb 16, 2024 Direct Common Stock
Restricted Stock Units 44.3K $1.2M $27.20 Feb 14, 2024 Direct Common Stock
Common Stock 5.68K $105K $18.50 Aug 16, 2024 By Spouse

Transactions reported by Kinnari Patel for Rocket Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.